Bulent Undar
Dokuz Eylul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: February 07, 2019
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Journal: Journal of laboratory physicians
Published: December 01, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 13, 2018
Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: June 21, 2018
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Journal: Clinical transplantation
Published: April 05, 2018
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 01, 2018
A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: November 15, 2017
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Journal: Expert opinion on pharmacotherapy
Published: August 09, 2016
The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: August 29, 2015
Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities.
Journal: Leukemia & lymphoma
Published: February 12, 2015
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 29, 2014
Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma.
Journal: Experimental hematology
Published: October 15, 2014
Last Updated: 09/26/2026